DSM-5 Criteria for Major Depressive Disorder with Anxious Distress Specifier
Major depressive disorder with anxious distress requires meeting full criteria for a major depressive episode PLUS at least 2 of 5 specific anxiety symptoms present during the majority of days of the depressive episode.
Core MDD Criteria (Must Be Met First)
To diagnose MDD with anxious distress, the patient must first meet DSM-5 criteria for a major depressive episode:
- Five or more of the following symptoms present during the same 2-week period, representing a change from previous functioning
- At least one symptom must be either (1) depressed mood or (2) loss of interest/pleasure:
- Depressed mood most of the day, nearly every day
- Markedly diminished interest or pleasure in activities
- Significant weight loss/gain or appetite changes
- Insomnia or hypersomnia
- Psychomotor agitation or retardation
- Fatigue or loss of energy
- Feelings of worthlessness or excessive guilt
- Diminished ability to concentrate or indecisiveness
- Recurrent thoughts of death or suicidal ideation
Anxious Distress Specifier Criteria
Once MDD is established, add the anxious distress specifier when at least 2 of the following 5 symptoms are present during the majority of days of the depressive episode 1, 2:
- Feeling keyed up or tense
- Feeling unusually restless
- Difficulty concentrating because of worry
- Fear that something awful may happen
- Feeling that the individual might lose control of themselves
Severity Levels
The anxious distress is further specified by severity 2:
- Mild: 2 symptoms present
- Moderate: 3 symptoms present
- Moderate-severe: 4-5 symptoms present
- Severe: 4-5 symptoms present with motor agitation
Clinical Context and Prevalence
Anxious distress is extremely common in MDD, affecting approximately 66-78% of depressed patients 3, 1, 2. This high prevalence underscores why DSM-5 added this specifier—anxiety symptoms in depression are the rule rather than the exception.
Key Clinical Associations
Patients meeting anxious distress criteria demonstrate 3, 2:
- Poorer psychosocial functioning and quality of life compared to MDD without anxious distress
- Higher rates of comorbid anxiety disorders (panic disorder, generalized anxiety disorder)
- More severe depression overall
- Association with mixed features (manic symptoms during depression)
- Association with psychotic features
- More common in unipolar depression than bipolar depression
Important Clinical Caveats
The anxious distress specifier is distinct from comorbid anxiety disorders—a patient can meet criteria for anxious distress without having a separate anxiety disorder diagnosis, though the two frequently co-occur 1, 2. The specifier captures anxiety symptoms that are part of the depressive presentation itself.
Assessment timing matters: More patients meet criteria when assessed for symptoms during the past week (9.4%) versus requiring symptoms for the majority of the entire depressive episode (3.9%) 4. The DSM-5 requires symptoms during the majority of days of the episode, not just current symptoms.
The anxious distress specifier applies to both unipolar and bipolar depression 5, though it appears more common in unipolar presentations 3.
Practical Assessment
Use structured assessment tools for reliable diagnosis 1, 2:
- DSM-5 Anxious Distress Specifier Interview (DADSI): Clinician-administered, excellent reliability
- CUDOS-A (Clinically Useful Depression Outcome Scale with Anxious distress): Self-report measure with validated subscale for anxious distress
These tools demonstrate that anxious distress symptoms correlate more strongly with anxiety measures than with depression or irritability measures, supporting their validity as a distinct clinical dimension 1, 2, 6.